These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 8676154)

  • 21. Botulinum toxin injection of spastic finger flexors in hemiplegic patients.
    Rodriquez AA; McGinn M; Chappell R
    Am J Phys Med Rehabil; 2000; 79(1):44-7. PubMed ID: 10678602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.
    Yelnik AP; Colle FM; Bonan IV; Vicaut E
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):845-8. PubMed ID: 17088333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
    Picelli A; Lobba D; Midiri A; Prandi P; Melotti C; Baldessarelli S; Smania N
    Clin Rehabil; 2014 Mar; 28(3):232-42. PubMed ID: 23945164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
    Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
    J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
    Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
    Francis HP; Wade DT; Turner-Stokes L; Kingswell RS; Dott CS; Coxon EA
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1547-51. PubMed ID: 15489384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.